JPS54160373A - Arylhydantoin - Google Patents

Arylhydantoin

Info

Publication number
JPS54160373A
JPS54160373A JP6317379A JP6317379A JPS54160373A JP S54160373 A JPS54160373 A JP S54160373A JP 6317379 A JP6317379 A JP 6317379A JP 6317379 A JP6317379 A JP 6317379A JP S54160373 A JPS54160373 A JP S54160373A
Authority
JP
Japan
Prior art keywords
arylhydantoin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6317379A
Other languages
English (en)
Inventor
Bofuii Jiyamiison Uiriamu
Jieemusu Rosu Uiriamu
Jiyooji Shimonzu Robin
Pomufuretsuto Buaaji Jiyon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of JPS54160373A publication Critical patent/JPS54160373A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP6317379A 1978-05-23 1979-05-22 Arylhydantoin Pending JPS54160373A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21352/78A GB1601310A (en) 1978-05-23 1978-05-23 Aryl hydantoins

Publications (1)

Publication Number Publication Date
JPS54160373A true JPS54160373A (en) 1979-12-19

Family

ID=10161451

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6317379A Pending JPS54160373A (en) 1978-05-23 1979-05-22 Arylhydantoin

Country Status (31)

Country Link
US (2) US4241073A (ja)
EP (1) EP0005647B1 (ja)
JP (1) JPS54160373A (ja)
KR (1) KR830000635B1 (ja)
AR (2) AR225143A1 (ja)
AT (1) AT366034B (ja)
AU (1) AU530968B2 (ja)
BE (1) BE876435A (ja)
BG (2) BG31799A3 (ja)
CA (1) CA1120481A (ja)
CH (2) CH639650A5 (ja)
CS (2) CS208654B2 (ja)
DD (1) DD143769A5 (ja)
DE (1) DE2963061D1 (ja)
DK (1) DK207579A (ja)
ES (1) ES480850A1 (ja)
FI (1) FI791614A (ja)
FR (1) FR2426681A1 (ja)
GB (1) GB1601310A (ja)
GR (1) GR68363B (ja)
HU (1) HU184648B (ja)
IL (1) IL57343A (ja)
LU (1) LU81300A1 (ja)
MX (1) MX5604E (ja)
NZ (1) NZ190512A (ja)
PL (2) PL125075B1 (ja)
PT (1) PT69648A (ja)
RO (2) RO79703A (ja)
SU (2) SU873878A3 (ja)
YU (1) YU120179A (ja)
ZA (1) ZA792501B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6317864A (ja) * 1986-07-11 1988-01-25 Mitsui Toatsu Chem Inc ヒダントイン類の製造方法
WO1995029910A1 (en) * 1994-04-28 1995-11-09 Yamanouchi Pharmaceutical Co., Ltd. Imidazolidinedione derivative

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3013647C2 (de) * 1980-04-09 1985-07-11 Degussa Ag, 6000 Frankfurt Verfahren zur Herstellung von 5-Arylidenhydantoinen (B)
US4431656A (en) * 1981-02-05 1984-02-14 Kanegafuchi Chemical Industry Company Limited 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
NL8800099A (nl) * 1987-01-31 1988-08-16 Sandoz Ag Pilocarpinederivaten en werkwijzen voor het bereiden en toepassen van deze derivaten.
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
HU214872B (hu) * 1990-04-27 1998-07-28 Orion-Yhtymä Oy Eljárás farmakológiailag aktív új katecholszármazékok és ezeket tartalmazó gyógyászati készítmények előállítására
FR2687153B1 (fr) * 1992-02-07 1994-05-13 Hoechst Ste Francaise Procede de preparation de la (thenyl-2)-5 hydantouine.
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (sv) * 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
KR20050044606A (ko) * 2001-11-30 2005-05-12 일라이 릴리 앤드 캄파니 퍼옥시솜 증식제에 의해 활성화된 수용체 아고니스트
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
FR2845000B1 (fr) * 2002-09-27 2005-05-27 Oreal Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
WO2008145562A1 (en) * 2007-05-30 2008-12-04 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors
JP2011502998A (ja) * 2007-11-01 2011-01-27 ザ ユーエイビー リサーチ ファウンデイション ウイルス感染の治療および予防
GB2463514C (en) * 2008-09-11 2018-09-26 Galapagos Nv Imidazolidine compounds and uses therefor
ITBO20090078A1 (it) * 2009-02-13 2010-08-14 Consiglio Nazionale Ricerche Composti per il trattamento del tumore alla prostata e procedimenti per la loro sintesi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR910275A (fr) * 1944-11-14 1946-06-03 Nouvelles hydantoïnes et leur procédé de préparation
US2479065A (en) * 1945-09-06 1949-08-16 Du Pont Preparation of 5-benzylhydantoin
US2861079A (en) * 1956-06-04 1958-11-18 Dow Chemical Co Process for making unsaturated hydantoins
GB846601A (en) * 1958-01-13 1960-08-31 British Oxygen Res And Dev Ltd Vinyl hydantoins
US3365296A (en) * 1964-05-18 1968-01-23 Gen Aniline & Film Corp Light-sensitive ultraviolet absorbing compounds and diazotype materials containing the same
US3395153A (en) * 1964-12-16 1968-07-30 United States Borax Chem 3, 5-dialkylhydantoins
JPS5136332B1 (ja) * 1970-12-09 1976-10-07
US3847933A (en) * 1970-12-09 1974-11-12 Exxon Research Engineering Co Acid catalyzed alkylation of hydantoin
US3932449A (en) * 1973-10-09 1976-01-13 Morton-Norwich Products, Inc. 5-(P-dimethylaminobenzyl) hydantoin
GB1575904A (en) * 1976-04-23 1980-10-01 Lilly Industries Ltd Phenyl piperazines
JPS54122276A (en) * 1978-03-15 1979-09-21 Kanegafuchi Chem Ind Co Ltd Preparation of 5-(2-thienyl) hydantion

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6317864A (ja) * 1986-07-11 1988-01-25 Mitsui Toatsu Chem Inc ヒダントイン類の製造方法
WO1995029910A1 (en) * 1994-04-28 1995-11-09 Yamanouchi Pharmaceutical Co., Ltd. Imidazolidinedione derivative

Also Published As

Publication number Publication date
RO79703A (ro) 1982-08-17
DK207579A (da) 1979-11-24
EP0005647A1 (en) 1979-11-28
GB1601310A (en) 1981-10-28
GR68363B (ja) 1981-12-23
AR224186A1 (es) 1981-10-30
CS208654B2 (en) 1981-09-15
AU530968B2 (en) 1983-08-04
IL57343A (en) 1982-09-30
BG31799A3 (en) 1982-03-15
PL222701A1 (ja) 1980-12-15
CH639650A5 (fr) 1983-11-30
CH643546A5 (fr) 1984-06-15
BE876435A (fr) 1979-11-21
KR830000635B1 (ko) 1983-03-23
ATA373379A (de) 1981-07-15
IL57343A0 (en) 1979-09-30
SU988190A3 (ru) 1983-01-07
NZ190512A (en) 1984-10-19
MX5604E (es) 1983-11-07
PL215773A1 (ja) 1980-07-14
ZA792501B (en) 1980-05-28
DE2963061D1 (en) 1982-07-29
EP0005647B1 (en) 1982-06-09
CS208653B2 (en) 1981-09-15
DD143769A5 (de) 1980-09-10
BG32115A4 (en) 1982-05-14
YU120179A (en) 1983-02-28
SU873878A3 (ru) 1981-10-15
CA1120481A (en) 1982-03-23
LU81300A1 (fr) 1980-12-16
PT69648A (en) 1979-06-01
PL125075B1 (en) 1983-03-31
AT366034B (de) 1982-03-10
AU4728979A (en) 1979-11-29
FR2426681B1 (ja) 1983-08-12
AR225143A1 (es) 1982-02-26
US4293563A (en) 1981-10-06
FI791614A (fi) 1979-11-24
FR2426681A1 (fr) 1979-12-21
HU184648B (en) 1984-09-28
PL119612B1 (en) 1982-01-30
US4241073A (en) 1980-12-23
RO76807A (ro) 1981-04-26
ES480850A1 (es) 1980-02-01

Similar Documents

Publication Publication Date Title
CS520079A2 (en) Nosna soustava snimaci hlavice
DE2967509D1 (en) Skin-equivalent
BG27580A1 (en) Two- poled pelvis- thight articulation- set
JPS54160373A (en) Arylhydantoin
CS74479A2 (en) Omezovac nadmerne proudove vodivosti televizni reprodukcni obrazovky
CS333379A2 (en) Upinaci zarizeni
GB2013938B (en) Servocontrollers
CS615079A2 (en) Zpusob vyroby inhibitoru enzymu
CS613879A2 (en) Zpusob vyroby fenylchinolizidinu
CS290179A2 (en) Plynova vybojka
CS846479A2 (en) Tkaci stroj
GB2015278B (en) Straight-through-repeater
GB2014109B (en) Exavators
EP0004713A3 (en) Twinski
EG13808A (en) Carbamoyl-oximes
GB2014996B (en) Arylacetamidocephalosporins
GB2013592B (en) Play-vehicle
GB2012937B (en) Refigerators
GB1558045A (en) Drumtensioning
GB1555634A (en) Sportsballs
CS686179A2 (en) Zpusob vyroby fenylchinolizidinu
JPS54163178A (en) Waterrspout
CS839779A2 (en) Zpusob vyroby benzimidazol-karbamatu
CS556679A2 (en) Zpusob vyroby derivatu chlorambucilu
BG31541A1 (en) Ornitopter